Recent Updates
Recently added Catalysts
LXRX

Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference

Key Takeaway: Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference
Price reaction · baseline $2.43 (2022-04-06 close) · hit after-hours · clean, no other LXRX news in the window
day 0 close · peak
+10.7%
day 1
+4.9%
day 3
-4.9%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus

Full Press Release Details

Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference.
Last updated: Apr 7, 2022